An Act relative to pharmaceutical access, costs and transparency
By Ms. Friedman, a petition (accompanied by bill, Senate, No. 771) of Cindy F. Friedman, Jason M. Lewis, Joanne M. Comerford, Michael O. Moore and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency. Health Care Financing.
Bill History
| Date | Branch | Action |
|---|---|---|
| 3/29/2021 | Senate | Referred to the committee on Health Care Financing |
| 3/29/2021 | House | House concurred |
| 6/29/2021 | Joint | Hearing scheduled for 07/13/2021 from 11:00 AM-04:00 PM in Virtual Hearing |
| 11/17/2021 | Senate | Accompanied by S736, S785, S786, S790, S803, S804 and H729, H1254, H1272, H1278, H1279, H1307 and H3787 |
| 11/17/2021 | Senate | Bill reported favorably by committee and referred to the committee on Senate Ways and Means |
| 2/3/2022 | Senate | Committee recommended ought to pass with an amendment substituting a new draft, S2651 |
| 2/3/2022 | Senate | Order relative to subject matter adopted |
| 2/3/2022 | Senate | Placed in the Orders of the Day for Thursday, February 10, 2022 |
| 2/10/2022 | Senate | Read second |
| 2/10/2022 | Senate | New draft substituted, see S2651 |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.